Felicitas Wagener

Suchergebnisse

• 2024

  Identification of human metabolites of fast skeletal troponin activators Tirasemtiv and Reldesemtiv for doping control purposes

  Euler, L., Deinert, K., Wagener, F., Walpurgis, K. & Thevis, M., 2024, (Elektronisch/ online veröffentlicht vor Drucklegung) in: Drug testing and analysis. 13 S.

  Publikation: Beitrag in Fachzeitschrift › Zeitschriftenaufsätze › Forschung › Begutachtung
• 2023

  Comparison of in vitro approaches for predicting the metabolism of the selective androgen receptor modulator RAD140

  Wagener, F., Naumann, N., Göldner, V., Görgens, C., Guddat, S., Karst, U. & Thevis, M., 08.07.2023, in: Analytical and bioanalytical chemistry. 415, S. 5657-5669 13 S.

  Publikation: Beitrag in Fachzeitschrift › Zeitschriftenaufsätze › Forschung › Begutachtung

  • In Vitro 100%
  • Selective Androgen Receptor Modulator 100%
  • Metabolic Pathway 100%
  • Metabolite 100%
  • In Vivo 66%
• 2022

  Determination and enantioselective separation of zilpaterol in human urine after mimicking consumption of contaminated meat by HPLC-MS/MS techniques

  Euler, L., Wagener, F., Thomas, A. & Thevis, M., 15.10.2022, in: Rapid communications in mass spectrometry : RCM. 36, 19, 10 S., e9357.

  Publikation: Beitrag in Fachzeitschrift › Zeitschriftenaufsätze › Forschung › Begutachtung

  • Zilpaterol 100%
  • Multiple Sclerosis 54%
  • Doping 36%
  • High Performance Liquid Chromatography 27%
  • Protein 9%

• Human In Vivo Metabolism and Elimination Behavior of Micro-Dosed Selective Androgen Receptor Modulator RAD140 for Doping Control Purposes

  Wagener, F., Euler, L., Görgens, C., Guddat, S. & Thevis, M., 20.07.2022, in: Metabolites. 12, 7, S. 666 1 S.

  Publikation: Beitrag in Fachzeitschrift › Zeitschriftenaufsätze › Forschung › Begutachtung

  Open Access

  • Doping 100%
  • Elimination 60%
  • Metabolic Pathway 40%
  • Time 40%
  • Sample 40%
• 2021

  Investigations into the elimination profiles and metabolite ratios of micro-dosed selective androgen receptor modulator LGD-4033 for doping control purposes

  Wagener, F., Guddat, S., Görgens, C., Angelis, Y. S., Petrou, M., Lagojda, A., Kühne, D. & Thevis, M., 04.11.2021, (Elektronisch/ online veröffentlicht vor Drucklegung) in: Analytical and bioanalytical chemistry. 12 S.

  Publikation: Beitrag in Fachzeitschrift › Zeitschriftenaufsätze › Forschung › Begutachtung

  Open Access

  • Doping 100%
  • Selective Androgen Receptor Modulator 66%
  • Urine Sampling 50%
  • Excretion 33%
  • Time 33%